Hope for Chronic Asthma Sufferers on New Research Studies

Chronic asthma sufferers could have new hope for comfort due to a couple of new research studies which are getting underway at Brigham and Women's Hospital (BWH). Scientists from BWH's Asthma Research Center are discovering whether two new therapies can relieve asthma signs and symptoms.

To begin with clinical trial, volunteers by using mild to moderate asthma will probably be randomly designated to receive vitamin D, along with an asthma controller medication, while some will probably be selected at random to obtain a placebo. Researchers think that vitamin D might play an indispensable role in cutting down on the inflammation that in fact interferes along with breathing.

Within the second clinical trial, individuals along with hard-to-control asthma will probably be randomly designated to receive a medication known as Imatinib or a placebo. Imatinib is accepted by the Food and Drug Administration (FDA) to treat leukemia, but scientists hypothesize which it could also benefit bronchial asthma sufferers since it works by targeting specific cells that could also play a task in asthma and inflammation.

"The consequences this research may present an excellent opportunity to bring comfort to long-suffering asthma affected individuals," said Elliot Israel, MD, director of the Asthma Research Center. "Moreover, during the studies, individuals can learn key asthma administration approaches."